Cargando…

Genetic polymorphisms of organic cation transporter 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes: A systematic review

BACKGROUND: Metformin is one of the most commonly used drugs for the treatment of type 2 diabetes mellitus (T2DM). Despite its widespread use, there are considerable interindividual variations in metformin response, with about 35% of patients failing to achieve initial glycemic control. These variab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mofo Mato, Edith Pascale, Guewo-Fokeng, Magellan, Essop, M. Faadiel, Owira, Peter Mark Oroma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076123/ https://www.ncbi.nlm.nih.gov/pubmed/29979413 http://dx.doi.org/10.1097/MD.0000000000011349

Ejemplares similares

Genetic polymorphisms of organic cation transporters 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes mellitus: a systematic review protocol
por: Mato, Edith Pascale Mofo, et al.
Publicado: (2018)

Contribution of the TCF7L2 rs7903146 (C/T) gene polymorphism to the susceptibility to type 2 diabetes mellitus in Cameroon
por: Guewo-Fokeng, Magellan, et al.
Publicado: (2015)

Association between the TCF7L2 rs12255372 (G/T) gene polymorphism and type 2 diabetes mellitus in a Cameroonian population: a pilot study
por: Nanfa, Dieudonne, et al.
Publicado: (2015)

Association between the rs12255372 variant of the TCF7L2 gene and obesity in a Cameroonian population
por: Ngwa, Elvis Ndonwi, et al.
Publicado: (2015)

Stimulated UCPCR Levels Are Lower in People With Type 1 Diabetes Than in Other Diabetes Types in Sub-Saharan Africa: Results From a Preliminary Cross-Sectional Study
por: Katte, Jean Claude, et al.
Publicado: (2022)

Proton Pump Inhibitors Inhibit Metformin Uptake by Organic Cation Transporters (OCTs)
por: Nies, Anne T., et al.
Publicado: (2011)

The Pro12Ala polymorphism in the PPAR-γ2 gene is not associated to obesity and type 2 diabetes mellitus in a Cameroonian population
por: Mato, Edith Pascale M., et al.
Publicado: (2016)

Erratum to: Investigation of the association between the TCF7L2 rs7903146 (C/T) gene polymorphism and obesity in a Cameroonian population: a pilot study
por: Nguimmo-Metsadjio, Aurelie, et al.
Publicado: (2017)

Investigation of the association between the TCF7L2 rs7903146 (C/T) gene polymorphism and obesity in a Cameroonian population: a pilot study
por: Nguimmo-Metsadjio, Aurelie, et al.
Publicado: (2017)

Impact of Promoter Polymorphisms on the Transcriptional Regulation of the Organic Cation Transporter OCT1 (SLC22A1)
por: Bokelmann, Kristin, et al.
Publicado: (2018)

Role of human organic cation transporter-1 (OCT-1/SLC22A1) in modulating the response to metformin in patients with type 2 diabetes
por: Kawoosa, Fizalah, et al.
Publicado: (2022)

Substrate-Dependent Inhibition of the Human Organic Cation Transporter OCT2: A Comparison of Metformin with Experimental Substrates
por: Hacker, Kristina, et al.
Publicado: (2015)

Role of Human Organic Cation Transporter 1 (hOCT1) Polymorphisms in Lamivudine (3TC) Uptake and Drug-Drug Interactions
por: Arimany-Nardi, Cristina, et al.
Publicado: (2016)

The Role of Immunometabolism in HIV-1 Pathogenicity: Links to Immune Cell Responses
por: Teer, Eman, et al.
Publicado: (2022)

Organic cation transporter 1 (OCT1) is involved in pentamidine transport at the human and mouse blood-brain barrier (BBB)
por: Sekhar, Gayathri N., et al.
Publicado: (2017)

Cloning and Functional Characterization of Dog OCT1 and OCT2: Another Step in Exploring Species Differences in Organic Cation Transporters
por: Meyer, Marleen Julia, et al.
Publicado: (2022)

Progestin Intrauterine Devices and Metformin: Endometrial Hyperplasia and Early Stage Endometrial Cancer Medical Management
por: Nwanodi, Oroma
Publicado: (2017)

The human transketolase-like proteins TKTL1 and TKTL2 are bona fide transketolases
por: Deshpande, Gaurang P., et al.
Publicado: (2019)

Association between Polymorphisms of OCT1 and Metabolic Response to Metformin in Women with Polycystic Ovary Syndrome
por: Chang, Hui Hua, et al.
Publicado: (2019)

Gender differences in metabolic risk factor prevalence in a South African student population
por: Smith, Carine, et al.
Publicado: (2009)

Differential hexosamine biosynthetic pathway gene expression with type 2 diabetes
por: Coomer, Megan, et al.
Publicado: (2014)

Persistent organic pollutants as risk factors for type 2 diabetes
por: Ngwa, Elvis Ndonwi, et al.
Publicado: (2015)

Transcription factor organic cation transporter 1 (OCT-1) affects the expression of porcine Klotho (KL) gene
por: Li, Yan, et al.
Publicado: (2016)

Mapping the evidence of hepatoprotective properties of Moringa oleifera from sub-Saharan African countries: a systematic review protocol
por: Muzumbukilwa, Willy Tambwe, et al.
Publicado: (2019)

The human organic cation transporter OCT1 mediates high affinity uptake of the anticancer drug daunorubicin
por: Andreev, Emil, et al.
Publicado: (2016)

Association between organic cation transporter genetic polymorphisms and metformin response and intolerance in T2DM individuals: a systematic review and meta-analysis
por: Peng, Aiyu, et al.
Publicado: (2023)

Organic Cation Transporter 1 (OCT1) mRNA expression in hepatocellular carcinoma as a biomarker for sorafenib treatment
por: Grimm, Daniel, et al.
Publicado: (2016)

Organic cation transporter 1 (OCT1) modulates multiple cardiometabolic traits through effects on hepatic thiamine content
por: Liang, Xiaomin, et al.
Publicado: (2018)

Interaction between OCT1 and LPIN1 polymorphisms and response to pioglitazone-metformin tablets in patients with polycystic ovary syndrome
por: Zeng, Haixia, et al.
Publicado: (2023)

Permeability of Metformin across an In Vitro Blood–Brain Barrier Model during Normoxia and Oxygen-Glucose Deprivation Conditions: Role of Organic Cation Transporters (Octs)
por: Sharma, Sejal, et al.
Publicado: (2023)

Reduced-Function SLC22A1 Polymorphisms Encoding Organic Cation Transporter 1 and Glycemic Response to Metformin: A GoDARTS Study
por: Zhou, Kaixin, et al.
Publicado: (2009)

Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance
por: Heise, Michael, et al.
Publicado: (2012)

Role of the Plasma Membrane Transporter of Organic Cations OCT1 and Its Genetic Variants in Modern Liver Pharmacology
por: Lozano, Elisa, et al.
Publicado: (2013)

Trimetazidine therapy for diabetic mouse hearts subjected to ex vivo acute heart failure
por: Breedt, Emilene, et al.
Publicado: (2017)

The dual role of the hexosamine biosynthetic pathway in cardiac physiology and pathophysiology
por: Cairns, Megan, et al.
Publicado: (2022)

DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma
por: Schaeffeler, Elke, et al.
Publicado: (2011)

Role of Organic Cation Transporter 1, OCT1 in the Pharmacokinetics and Toxicity of cis-Diammine(pyridine)chloroplatinum(II) and Oxaliplatin in Mice
por: Li, Shuanglian, et al.
Publicado: (2010)

Risk factors for colonization and infection with multidrug-resistant Pseudomonas aeruginosa in intensive care unit: protocol for a systematic review and meta-analysis
por: Eyebe, Serge, et al.
Publicado: (2022)

Loss of organic cation transporter 3 (Oct3) leads to enhanced proliferation and hepatocarcinogenesis
por: Vollmar, Johanna, et al.
Publicado: (2017)

Partial inhibition of the ubiquitin–proteasome system ameliorates cardiac dysfunction following ischemia–reperfusion in the presence of high glucose
por: Adams, Buin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qn159o4odgrkl8ei5h46dlaeo7